{"id":25297,"date":"2013-02-08T08:45:02","date_gmt":"2013-02-08T06:45:02","guid":{"rendered":"http:\/\/www.erzurumflas.com\/?p=25297"},"modified":"2013-02-09T15:40:24","modified_gmt":"2013-02-09T13:40:24","slug":"500-bin-kanser-hastasina-yerli-umut","status":"publish","type":"post","link":"https:\/\/www.erzhaber.com.tr\/?p=25297","title":{"rendered":"500 bin kanser hastas\u0131na yerli umut"},"content":{"rendered":"

Kanser hastalar\u0131 i\u00e7in ithal edilen 4 bin 200 TL’lik Evorabin isimli ilaca alternatif yerli \u00fcretime ba\u015fland\u0131.<\/p>\n

<\/p>\n

B\u00f6ylece\u00a0SGK<\/a>‘n\u0131n \u00f6demeleri ge\u00e7 yapmas\u0131 durumunda vatanda\u015f\u0131n ya\u015fad\u0131\u011f\u0131 ma\u011fduriyet bitecek.<\/p>\n

\nSa\u011fl\u0131k Bakanl\u0131\u011f\u0131 kanser tedavisi g\u00f6ren 500 bin hastaya umut verecek \u00e7al\u0131\u015fmay\u0131 tamamlad\u0131.<\/em><\/p>\n

\u00c7al\u0131\u015fma kapsam\u0131nda kutusu 4 bin 241 TL’ye ithal edilen Evorabin adl\u0131 ilac\u0131n yerli olarak \u00fcretilmesi sa\u011fland\u0131. B\u00f6ylece hem devlet 21 milyon TL tasarruf edecek hem de hastalar\u0131n ila\u00e7 bulma s\u0131k\u0131nt\u0131s\u0131 sona erecek.<\/p>\n

T\u00fcm kanser t\u00fcrlerinde kullan\u0131lan ilac\u0131n y\u00fcksek fiyat\u0131 ve bulunmas\u0131nda ya\u015fanan g\u00fc\u00e7l\u00fckler s\u0131k\u0131nt\u0131ya yol a\u00e7t\u0131. Ba\u015fbakan Erdo\u011fan’a iletilen \u015fikayetler sonras\u0131 yerli \u00fcretim ara\u015ft\u0131rmalar\u0131 ba\u015flad\u0131. Bu kapsamda \u00e7al\u0131\u015fma ba\u015flatan \u0130la\u00e7 ve T\u0131bbi Cihaz Kurumu yetkilileri ilac\u0131n yerli \u00fcretimine ge\u00e7ilmesi i\u00e7in T\u00fcrk firmalarla g\u00f6r\u00fc\u015fmeler yapt\u0131.<\/p>\n

\nGEC\u0130KME MA\u011eDUR ED\u0130YORDU\u00a0<\/strong><\/em><\/p>\n

G\u00f6r\u00fc\u015fmeler olumlu ge\u00e7erken ilac\u0131n \u00fcretimine karar verildi. T\u00fcrkiye’de \u00fcretilmeyen ve de\u011fi\u015fik nedenlerden dolay\u0131 bulunmayan ila\u00e7lar, bakanl\u0131k taraf\u0131ndan ithal izni verilerek T\u00fcrk Eczac\u0131lar Birli\u011fi \u00fczerinden getirtiliyordu.<\/p>\n

Bu durumda\u00a0SGK<\/a>\u00a0fiyat komisyonunun ila\u00e7lar\u0131n geri \u00f6deme listesine al\u0131nabilmesi i\u00e7in y\u0131lda 2 defa toplanmas\u0131 ila\u00e7lar\u0131n paras\u0131n\u0131 vatanda\u015f\u0131n cebinden \u00f6demesine yol a\u00e7\u0131yordu.<\/p>\n

Geri \u00f6demeler gecikince de vatanda\u015fma\u011fdur oluyordu. Yerli \u00fcretimle birlikte art\u0131k ila\u00e7lar\u0131n \u00fccreti hemen kar\u015f\u0131lanacak.Hastalar re\u00e7eteyle istedi\u011fi eczaneden ilac\u0131 alabilecek.<\/p>\n

4\u2019te 1 fiyat\u0131na \u00fcretilecek<\/strong><\/p>\n

Evorabin, ithal edilirken kutu ba\u015f\u0131na 4 bin 241 TL \u00f6deniyordu. Yerli \u00fcretim sayesinde bu rakam 4’te 1 fiyat\u0131na d\u00fc\u015fecek. \u00d6ncelikle kutu ba\u015f\u0131na bin 200 lira olarak belirlenen ilac\u0131n fiyat\u0131 zamanla a\u015fa\u011f\u0131 \u00e7ekillecek. \u0130la\u00e7 ve T\u0131bbi Cihaz Kurumu verilerine g\u00f6re, ilaca 4 y\u0131lda 21 milyon 597 bin TL \u00f6dendi.<\/p>\n

Karaborsaya d\u00fc\u015f\u00fcyor<\/strong><\/p>\n

\u0130la\u00e7 ve T\u0131bbi Cihaz Kurumu yetkilileri ila\u00e7lar\u0131n ithal edilirken pahal\u0131l\u0131k nedenlerini ara\u015ft\u0131rd\u0131. Bu kapsamda yetkililer ila\u00e7lar\u0131n piyasada karaborsa y\u00f6ntemiyle sat\u0131ld\u0131\u011f\u0131n\u0131 belirledi. Piyasaya y\u00f6nelik denetimler s\u0131kla\u015ft\u0131r\u0131l\u0131rkenbaz\u0131 eczaneler i\u00e7in soru\u015fturmaba\u015flat\u0131ld\u0131. Soru\u015fturman\u0131n ard\u0131ndan konunun yarg\u0131ya intikal etmesi i\u00e7in de \u00e7al\u0131\u015fmalar ba\u015flat\u0131ld\u0131.<\/p>\n

<\/dt>\n: 500 bin kanser hastas\u0131na yerli umut<\/dd>\n<\/dl>\n","protected":false},"excerpt":{"rendered":"
Kanser hastalar\u0131 i\u00e7in ithal edilen 4 bin 200 TL’lik Evorabin isimli ilaca alternatif yerli \u00fcretime ba\u015fland\u0131. B\u00f6ylece\u00a0SGK‘n\u0131n \u00f6demeleri ge\u00e7 yapmas\u0131 durumunda vatanda\u015f\u0131n ya\u015fad\u0131\u011f\u0131 ma\u011fduriyet bitecek. Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 kanser tedavisi g\u00f6ren 500 bin hastaya umut verecek \u00e7al\u0131\u015fmay\u0131 tamamlad\u0131. \u00c7al\u0131\u015fma kapsam\u0131nda kutusu 4 bin 241 TL’ye ithal edilen Evorabin adl\u0131 ilac\u0131n yerli olarak \u00fcretilmesi […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[20992,611,662,5210,5676],"class_list":["post-25297","post","type-post","status-publish","format-standard","hentry","category-saglik","tag-erzurum","tag-haber","tag-haberler","tag-kanser","tag-umut"],"_links":{"self":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/posts\/25297","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=25297"}],"version-history":[{"count":0,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/posts\/25297\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=25297"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=25297"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=25297"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}